New Cancer Immunotherapy Opdivo Approved by FDA December 22, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD
Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer January 13, 2015December 14, 2022 Matthew Tontonoz
Big News: FDA Approves Opdivo (Nivolumab) for Lung Cancer March 4, 2015December 14, 2022 Matthew Tontonoz
What Cancer Patients Need to Know About the Opdivo Approval March 13, 2015December 14, 2022 Emily Helck
Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma March 24, 2015December 14, 2022 Matthew Tontonoz